The purchase of the Offered Shares by OMF Fund I will be part of a larger offering (the "Offering") which involves the concurrent issue and sale of 41,200,000 newly issued ordinary shares of EMED on a private placement basis to
The Offered Shares to be purchased by OMF Fund I represent approximately 11.2% of the currently outstanding ordinary shares (the "Ordinary Shares") of EMED and approximately 9.8% of the outstanding Ordinary Shares assuming completion of the Offering.
Orion currently owns, or exercises control or direction over, 67,954,787 Ordinary Shares, representing approximately 5.4% of the currently outstanding Ordinary Shares. In addition, Orion currently owns, or exercises control over, approximately £2,784,338 principal amount of convertible notes issued by EMED (with the principal amount being calculated as of
Following completion of the Offering, Orion will own, or exercise control or direction over, 207,954,787 Ordinary Shares, representing approximately 14.5% of the then outstanding Ordinary Shares. Assuming the conversion of Orion's convertible notes at
Orion is acquiring the Offered Shares for investment purposes. Orion has no current plan or proposal which relates to, or would result in, acquiring additional ownership or control over the securities of EMED. Depending on market conditions, Orion's view of EMED's prospects and other factors considered relevant by Orion, Orion may acquire additional securities of EMED from time to time in the future, in the open market or pursuant to privately negotiated transactions, or may sell all or a portion of its securities of EMED.
Orion's address is Cannon's Court,
Certain statements in the press release are forward-looking statements and are prospective in nature, including statements with respect to Orion's future intentions regarding the securities of EMED. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Such forward-looking statements should therefore be construed in light of such factors, and Orion is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Most Popular Stories
- Consumer Prices Edge Up, Surprising Economists
- Steris to Add 100 Jobs in Birmingham
- Clinton Rallies New England Women
- Market Jolt Offers a Reality Check for Investors
- Stocks Close Out Best Week in Nearly 2 Years
- Do Voters Want Compromise?
- Timeline for New York Ebola Doctor
- Microsoft Earnings Drive Stocks Higher
- 'Kissing Congressman' Admits Mistake in Reelection Bid
- Ebola in New York, Mali Raises Travel Jitters